science pharmaceutical expo biotech jobs
Originally published online as doi:10.1189/jlb.0603265 on March 12, 2004

Published online before print March 12, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0603265v1
75/6/1062    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mamputu, J. C.
Right arrow Articles by Renier, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mamputu, J. C.
Right arrow Articles by Renier, G.
(Journal of Leukocyte Biology. 2004;75:1062-1069.)
© 2004 by Society for Leukocyte Biology

Advanced glycation end-products increase monocyte adhesion to retinal endothelial cells through vascular endothelial growth factor-induced ICAM-1 expression: inhibitory effect of antioxidants

J. C. Mamputu and G. Renier1

CHUM Research Centre, Notre-Dame Hospital, Department of Medicine, University of Montreal, Quebec, Canada

1 Correspondence: CHUM Research Centre, Notre-Dame Hospital, J-A. de Seve Pavilion, Room Y-3622, 1560 Sherbrooke Street East, Montreal, Quebec, Canada H2L 4M1. E-mail: genevieve.renier{at}umontreal.ca

Accumulating evidence indicates a role for advanced glycation end-products (AGEs) in the development of diabetic retinopathy. In the present study, we examined the in vitro effect of AGEs on human monocyte adhesion to bovine retinal endothelial cells (BRECs) and the molecular mechanisms involved in this effect. Treatment of cultured BRECs with AGEs led to a significant increase in monocyte adhesion and intercellular cell adhesion molecule-1 (ICAM-1) expression. These effects were inhibited by antioxidants including gliclazide and vitamins C and E. On the basis of the stimulatory effect of AGEs on vascular endothelial growth factor (VEGF) secretion by retinal endothelial cells, the role of this growth factor as mediator of AGE-induced monocyte adhesion to BRECs was next investigated. Incubation of BRECs with VEGF increased monocyte adhesion to these cells and enhanced ICAM-1 expression. Treatment of BRECs with an anti-VEGF antibody abrogated AGE-induced monocyte adhesion and ICAM-1 expression. Finally, incubation of BRECs with protein kinase C (PKC) and nuclear factor (NF)-{kappa}B inhibitors suppressed monocyte adhesion and ICAM-1 expression elicited by AGEs and VEGF. Taken together, these data indicate that AGEs increase monocyte adhesion to BRECs and that this effect is mediated through VEGF-induced ICAM-1 expression. They also demonstrate that this effect is oxidative stress-sensitive and involves PKC and NF-{kappa}B-dependent signaling pathways.

Key Words: AGE • VEGF • adhesion molecules • gliclazide




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
J. Treweek, S. Wee, G. F. Koob, T. J. Dickerson, and K. D. Janda
Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease
PNAS, July 10, 2007; 104(28): 11580 - 11584.
[Abstract] [Full Text] [PDF]